Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Preferred Stock Liabilities (2021 - 2022)

Cardio Diagnostics Holdings' Preferred Stock Liabilities history spans 2 years, with the latest figure at $65.5 million for Q3 2022.

  • For Q3 2022, Preferred Stock Liabilities changed N/A year-over-year to $65.5 million; the TTM value through Sep 2022 reached $65.5 million, changed N/A, while the annual FY2021 figure was $65.0 million, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q3 2022 was $65.5 million at Cardio Diagnostics Holdings, up from $65.0 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $65.5 million in Q3 2022 and bottomed at $65.0 million in Q4 2021.